Three cachexia phenotypes and the impact of fat‐only loss on survival in FOLFIRINOX therapy for pancreatic cancer

BACKGROUND: By the traditional definition of unintended weight loss, cachexia develops in ~80% of patients with pancreatic ductal adenocarcinoma (PDAC). Here, we measure the longitudinal body composition changes in patients with advanced PDAC undergoing 5‐fluorouracil, leucovorin, irinotecan, and ox...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cachexia Sarcopenia Muscle
Main Authors: Kays, Joshua K., Shahda, Safi, Stanley, Melissa, Bell, Teresa M., O'Neill, Bert H., Kohli, Marc D., Couch, Marion E., Koniaris, Leonidas G., Zimmers, Teresa A.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6104116/
https://ncbi.nlm.nih.gov/pubmed/29978562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12307
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados